Acor­da CTO Baty­cky is jump­ing ship to run a biotech; Mo­tif gets a PDU­FA date

→ We have one more news item about a biotech ex­ec on the move. Acor­da‘s $ACOR chief tech­nol­o­gy of­fi­cer Rick Baty­cky is leav­ing the com­pa­ny to take the CEO job at an undis­closed pri­vate biotech. David Lawrence, Acor­da’s chief of busi­ness op­er­a­tions, is be­ing charged with the com­pa­ny’s Chelsea, MA man­u­fac­tur­ing fa­cil­i­ty, which pro­duces In­bri­ja, now un­der reg­u­la­to­ry re­view as Acor­da braces for gener­ic com­pe­ti­tion to Ampyra.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.